A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

• Status: Completed
• Trial end date: 2014-09-03
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in Europe. The aim of this study is to investigate a retrospective database assessment of clinical effectiveness in type 2 diabetes patients treated with liraglutide from primary care centers in Sweden.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Liraglutide; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patients from EMR (electronic medical record) system in the primary care in Sweden

• Patients equal to or more than 18 years of age

• Starting treatment with liraglutide or sitagliptin from January 2010 to December 2013

• Minimum of 180 days of prior follow-up/history within the database before their index date

Exclusion Criteria:

• Patients with cancer, end stage liver disease, end stage renal failure (non-diabetes related)

• Female patients with gestational diabetes during pregnancy

• Patients with previous GLP-1 (glucagon-like peptide-1) or DPP-IV (dipeptidyl peptidase-4 ) inhibitor use, i.e. patients should be incretin naïve